Results 21 to 30 of about 97,795 (300)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma

open access: yesTechnology in Cancer Research & Treatment, 2021
Purpose: Induction chemotherapy plus concurrent chemoradiotherapy and concurrent chemoradiotherapy alone are both standard treatment regimens for managing locally advanced nasopharyngeal carcinoma.
Guoqiang Xu MD   +9 more
doaj   +1 more source

The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma

open access: yesMedicina, 2021
Background and Objectives: There is evidence or consensus on the use of 18F-2-fluorodeoxyglucose-positron emission tomography with computed tomography (PET-CT) in evaluating the effects of treatment at 12 weeks after chemoradiotherapy for head and neck ...
Hoshino Terada   +4 more
doaj   +1 more source

Clinical stage after chemoradiotherapy.

open access: yes, 2014
Clinical stage after chemoradiotherapy.
Meng Su (136681)   +5 more
core   +1 more source

Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials

open access: yesFrontiers in Oncology, 2022
ObjectivesTo assess the clinical efficacy and toxicity of nimotuzumab in combination with chemoradiotherapy or chemoradiotherapy alone in the treatment of cervical cancer.MethodsThe PubMed, Embase, Cochrane Library, Web of Science, China National ...
Yan Yuan   +13 more
doaj   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

Construction of a novel CD8T cell-related index for predicting clinical outcomes and immune landscape in ovarian cancer by combined single-cell and RNA-sequencing analysis

open access: yesDiscover Oncology
Background CD8T cells, also known as cytotoxic T lymphocytes, play a key role in the tumor immune microenvironment (TME) and immune response. The aim of this study was to explore the potential role of CD8T cell-associated biomarkers in predicting ...
Yu Zhang   +3 more
doaj   +1 more source

Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients

open access: yesWorld Journal of Surgical Oncology, 2020
Background The proline-rich protein 11 (PRR11) is a newly identified oncogene associated with a poor prognosis in several human cancers. Nonetheless, research on its role in ovarian cancer (OC) remains largely understudied.
Yu Zhan   +6 more
doaj   +1 more source

Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma

open access: yesFrontiers in Oncology, 2021
PurposeTo identify whether chemoradiotherapy improves survival of stage I nasopharyngeal carcinoma (NPC).Materials and MethodsNPC patients were extracted from the Surveillance, Epidemiology, and End Results database between 2010 and 2015.
Jia-Lin Ma   +3 more
doaj   +1 more source

Chemoradiotherapy in pancreatic carcinoma

open access: yesIndian Journal of Medical and Paediatric Oncology, 2009
AbstractPancreatic cancer patients present late in their course and surgical resection as a modality of treatment is of limited value. Majority develop loco-regional failure and distant metastasis, therefore, adjuvant therapy comprising of radiotherapy and chemotherapy are useful treatment options to achieve higher loco-regional control.
Pathy Sushmita, Chander Subhash
openaire   +4 more sources

Treatment Regimens for Adjuvant Chemoradiotherapy Cohort.

open access: yes, 2016
Treatment Regimens for Adjuvant Chemoradiotherapy Cohort.
Vishal Gupta (763297)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy